HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Our participation in CPHI Milan was a resounding success! With over 30 scheduled meetings at our stand, the event provided a valuable opportunity to engage productively with key players in the pharmaceutical and biotechnology industries.
Our stand perfectly reflected HTL Biotechnology’s image, creating a welcoming and professional environment that encouraged enriching discussions and new partnerships. This ideal setting facilitated fruitful and promising connections for the future of our company and its innovative projects.
Thank you to all the partners and visitors who contributed to the success of this event. We look forward to continuing these discussions and collaborating to drive innovation in our sector.
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.